What are the different types of PMOS?
According to the 2012 NIH Evidence-Based Workshop on PCOS, PMOS can be grouped into four sub-types based on the presence of hyperandrogenism, ovulatory dysfunction and/or polycystic ovaries.
PMOS is a complex, multi-system disorder that affects different individuals differently; researchers have identified four different types of PMOS based on core symptoms.[1]
In this article we explore four different types or phenotypes of PMOS.
The most common type of PMOS, affecting c.70% of individuals with the condition, combines all three diagnostic criteria including androgen excess, ovulatory dysfunction and polycystic ovaries:[2]
Androgen excess (AE) (or hyperandrogenism), higher than usual levels of androgens, a type of sex hormone naturally produced in the ovaries and in the adrenal glands located on the top of your kidneys;[3][4]
Ovulatory dysfunction (OD), failure to ovulate on a regular cycle leading to irregular or absent periods; and
Polycystic ovaries (PCO), the presence of multiple follicles or cysts around the outside of the ovary, often referred to as a “string of pearls”.[5]
In addition to these diagnostic criteria, PMOS is associated with:
High body mass index (BMI), the ratio of your weight in kilogram divided by the square of your height in meters, with a value higher than 25 or 30 being classified as overweight or obese respectively;[6]
High ovarian reserve, an estimate of the number of remaining eggs compared to the average for individuals your age (noting that this is not a measure of quality of the eggs);[7]
High fasting insulin, the level of insulin (the natural hormone that turns food into energy)[8] in your bloodstream, with levels greater than 25 milli international units per liter (mIU/L) in a fasting test classified as hyperinsulinemia;[9]
High cholesterol in the form of high levels (>150 milligram per deciliter) of low-density lipids (LDLs) and low levels of high-density lipids (HDLs);[10]
High levels of anti-Müllerian hormone (AMH),[11] a protein produced by granulosa cells within ovarian follicles and a measure of ovarian reserve;[12] and
Higher resistance to clomiphene, failure to ovulate over the course of 3 cycles when treated with clomiphene citrate (CC), the medication commonly used to stimulate ovulation during fertility treatment.[13][14][15]
Another c.20% of individuals with PMOS exhibit androgen excess (AE) and polycystic ovaries (PCO) but not ovulatory dysfunction (OD).[16]
A further c.10% of individuals with PMOS exhibit androgen excess (AE) and ovulatory dysfunction (OD) but not polycystic ovaries (PCO).[17]
The remaining c.5% of individuals
